Gedea Biotech Ab
Clinical trials sponsored by Gedea Biotech Ab, explained in plain language.
-
New vaginal tablet shows promise for yeast infections in small study
Disease control CompletedThis study tested a new vaginal tablet (Gedea Pessary) in 26 adult women with yeast infections. Women used one tablet daily for 6 days. The main goal was to see if symptoms like itching and burning went away by day 7 or 14. The study also checked if the infection came back by day…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
New vaginal tablet shows promise in taming recurrent bacterial vaginosis
Disease control CompletedThis study tested the safety of using pHyph, a vaginal tablet that naturally restores acidity, for 12 days in 32 adult women with bacterial vaginosis (BV). BV is a common infection causing unpleasant discharge and odor, and often returns after antibiotic treatment. The goal was t…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Jun 02, 2026 11:40 UTC